연구동향 분석

Adjunctive markers for classification and diagnosis of central nervous system tumors: results of a multi-center neuropathological survey in Korea

차윤진 김세훈 김나래 2020년

논문상세정보
    • 저자 차윤진 김세훈 김나래
    • 제어번호 106641958
    • 학술지명 Journal of Pathology and Translational Medicine
    • 권호사항 Vol. 54 No. 2 [ 2020 ]
    • 발행처 대한병리학회
    • 발행처 URL http://www.pathology.or.kr
    • 자료유형 학술저널
    • 수록면 165-170
    • 언어 English
    • 출판년도 2020
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Adjunctive markers for classification and diagnosis of central nervous system tumors: results of a multi-center neuropathological survey in Korea' 의 참고문헌

  • Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lowergrade glioma
    Kannan K [2012]
  • WHO classification of tumours of the central nervous system
    Louis DN [2016]
  • Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
    Arita H [2013]
  • TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma
  • TERT promoter mutations and risk of recurrence in meningioma
    Sahm F [2016]
  • Supratentorial gangliogliomas : histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8years
    Luyken C [2004]
  • Significance of Simpson grading system in modern meningioma surgery : integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas
    Oya S [2012]
  • Risk stratification of childhood medulloblastoma in the molecular era : the current consensus
    Ramaswamy V [2016]
  • New molecular considerations for glioma : IDH, ATRX, BRAF, TERT, H3 K27M
    Karsy M [2017]
  • Medulloblastoma : clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
    Ellison DW [2011]
  • MGMT gene silencing and benefit from temozolomide in glioblastoma
    Hegi ME [2005]
  • IDH1 and IDH2 mutations in gliomas
    Yan H [2009]
  • IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
    Leeper HE [2015]
  • High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression
    Goutagny S [2014]
  • Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors
  • Gangliogliomas : an intriguing tumor entity associated with focal epilepsies
    Blumcke I [2002]
  • Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
    Liu XY [2012]
  • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study : 5-year analysis of the EORTC-NCIC trial
    Stupp R [2009]
  • Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E)mutation and expression
    Chappe C [2013]
  • Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up
    Lanzafame S [2000]
  • Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas
    Ozen O [2005]
  • Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
    Schindler G [2011]
  • Altered telomeres in tumors with ATRX and DAXX mutations
    Heaphy CM [2011]
  • Adult infiltrating gliomas with WHO 2016 integrated diagnosis : additional prognostic roles of ATRX and TERT
    Pekmezci M [2017]